

ISTA Pharmaceuticals Announces Conference Call and Webcast of Third Quarter 2011 Financial Results
October 18, 2011 07:30 ET
ISTA Pharmaceuticals Announces Conference Call and Webcast of Third Quarter 2011 Financial Results
IRVINE, CA--(Marketwire - Oct 18, 2011) - ISTA Pharmaceuticals, Inc. (
Date: Tuesday, November 1, 2011
Time: 4:30 p.m. Eastern Time
Conference call access:
Internet: [ www.istavision.com ]
Domestic dial-in: 866.825.1692
International dial-in: 617.213.8059
Passcode: 90996630
To access the 24-hour audio replay, U.S. and Canadian participants may dial 888.286.8010; international participants may dial 617.801.6888. The access code for the replay is 93234261. This conference call will be webcast live and archived on ISTA's website until December 2, 2011.
About ISTA Pharmaceuticals
ISTA Pharmaceuticals, Inc. is a fast growing and the third largest branded prescription eye care business in the United States with an expanding focus on allergy therapeutics. ISTA currently markets four products, including treatments for ocular inflammation and pain post-cataract surgery, glaucoma and ocular itching associated with allergic conjunctivitis. The company's development pipeline contains additional candidates in various stages of development to treat dry eye, ocular inflammation and pain, and nasal allergies. Headquartered in Irvine, California, ISTA generated revenues of $156.5 million in 2010. For additional information about ISTA, please visit the corporate website at [ www.istavision.com ].